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ABSTRACT 
Whether warm ischemia during the time to complete the vascular anastomoses 
determines renal allograft function has not been investigated systematically. We 
investigated the effect of anastomosis time on allograft outcome in 669 first, 
single kidney transplantations from brain dead donors. Anastomosis time 
independently increased the risk of delayed graft function (odds ratio per minute 
(OR) 1.05, 95% confidence interval (CI) 1.02 – 1.07, p < 0.001) and 
independently impaired allograft function after transplantation (p = 0.009, mixed-
models repeated-measures analysis). In a subgroup of transplant recipients, 
protocol-specified biopsies at 3 months (n=186), 1 year (n=189), and 2 years 
(n=153) were blindly reviewed. Prolonged anastomosis time independently 
increased the risk of interstitial fibrosis and tubular atrophy on these protocol-
specified biopsies post-transplant (p < 0.001, generalized linear models). In 
conclusion, prolonged anastomosis time is not only detrimental for renal allograft 
outcome immediately after transplantation, also longer-term allograft function and 
histology are affected by the duration of this warm ischemia.  
 
 
 
 
 
 
 
Introduction: 
 
Ischemia-reperfusion injury is a major threat to the renal transplant.  Prolonged 
cold ischemia time impairs allograft function, allograft histology, and survival (1-
4). In addition, warm ischemia prior to organ procurement impacts organ viability 
(5-7). Furthermore, the organ is exposed to slow rewarming during 
transplantation, when the kidney is removed from the ice but not yet reperfused 
in the recipient. This period of warm ischemia is called the anastomosis time. It 
has been sporadically demonstrated that prolonged anastomosis time increased 
the risk of delayed graft function (DGF)(8, 9). Only recently, an independent 
effect of anastomosis time on patient survival has been demonstrated(10). 
However, the authors did not observe an independent effect on allograft survival 
and allograft survival was not censored for patient death. Moreover, no 
association with allograft function or histology was investigated. Thus, the precise 
impact of anastomosis time on the renal allograft remains unclear. Given the fact 
that kidney temperature increases logarithmically during anastomosis time (11), 
we hypothesized that anastomosis time associates with DGF, allograft histology, 
function and survival.  
 
Methods: 
 
Study population 
All patients who received a first and single kidney transplant from a brain dead 
donor at the University Hospitals Leuven, in Leuven, Belgium, between January 
1, 2004 and December 31, 2012 were included in this cohort study. When donor 
warm ischemia time was reported to be present due to a delay in cold flush after 
cross clamping of the aorta, recipients were excluded from the study.  
Clinical data 
The clinical data of both donors and recipients were prospectively collected in 
electronic clinical patient charts, which were used for clinical patient management 
and directly linked to the database used in this study. Donation after brain death 
was categorized as standard (SCD) or expanded criteria donation (ECD). ECD 
was defined as any kidney procured from a donor aged ≥ 60 years or any donor 
aged 50-59 years with two of the following three criteria: cerebrovascular 
accident as cause of death, medical history of arterial hypertension and terminal 
creatinine > 1.5 mg/dL (or > 133 μmol/L) (12). Recipient BMI was measured on 
the day of transplantation. Anastomosis time and cold ischemia time were 
recorded during transplantation. Anastomosis time was defined as the time 
between the allograft leaving the ice and restoration of blood flow by opening of 
the vascular clamps in the recipient. During this time period, all kidneys were 
wrapped in an ice blanket and irrigated with ice water every 5 minutes (Figure 
S1). 
All post-transplantation data were collected during routine clinical follow-up of the 
transplant recipients. DGF was defined as need for dialysis within the first seven 
days after transplantation. Allograft function was measured by the abbreviated 
MDRD formula at 3 months, 1, 2 and 3 years post-transplant. We defined acute 
rejection as treatment for rejection within the first three months after 
transplantation. All-cause allograft failure was taken as time from transplantation 
to graft nephrectomy or return to dialysis, whichever was earlier, or to death of 
the patient with a functioning allograft. Survival of the patient was defined as time 
from transplantation until death. All patients provided written consent to use their 
clinical data for study purposes.  
 
Allograft biopsies 
In a subgroup of recipients, those transplanted between March 2004 and October 
2007, percutaneous, ultrasound-guided core needle biopsies (2x14-gauge 
needle) of the allografts were performed at 3, 12, and 24 months after 
transplantation. All biopsy specimens were scored at the time by one pathologist 
according to the revised Banff criteria (13). Only biopsy specimens that were 
rescored again by the pathologist blinded for the clinical information were 
included in this study. The Chronic Allograft Damage Index (CADI) was 
calculated as the sum of histologic scores for tubular atrophy, interstitial fibrosis, 
interstitial inflammation, mesangial matrix increase, vascular intimal thickening 
and glomerulosclerosis (14). 
 
Vascular calcifications and arterial stiffness 
Arterial calcifications at the time of transplantation could potentially prolong the 
process to anastomose the vessels as well as negatively impact allograft 
performance. Its presence was not prospectively recorded during surgery. 
Therefore, we included the results from aortic calcifications measured by means 
of lumbar X-ray in 253 randomly selected transplant recipients at the time of 
admission for kidney transplantation between October 2006 and March 2009. 
These measurements were performed as part of a study published by our group 
(15). From 250 of these 253 recipients, anastomosis time was recorded. Details 
on aortic calcification measurement are reported in the Supplemental Methods. 
In addition, arterial stiffness was measured during the second postoperative 
week in the same study cohort (15). Measurements were made in a quiet, 
temperature-controlled room after 10 minutes of supine rest. Blood pressure was 
measured with a validated oscillometric device (Omron 507, Omron Corp, Japan) 
in the non-fistula arm (n = 123). The mean of three measurements taken one 
minute apart was used. Pulse wave velocity (PWV) was measured with the 
SphygmoCor system, after abstinence from caffeine or smoking and after an 
overnight fast without intake of antihypertensive drugs (n = 116). Intima media 
thickness (IMT) was measured with Philips Envisor in a smaller subgroup of this 
study cohort (n = 73). Details on IMT measurements are reported in the 
Supplemental Methods.  
 
 
Statistical analysis 
Follow-up analysis of the study population ended July 1, 2014.  
Discrete variables were reported as a percentage and continuous variables as 
mean ± standard deviation (SD) or as median and interquartile range (IQR) when 
data were skewed. Correlations were assessed by means of Pearson or 
Spearman analysis, as appropriate. The association of DGF with each variable 
(donor serum creatinine, donor age, ECD vs. SCD, recipient age, recipient BMI, 
total number of HLA mismatch, cold ischemia time, anastomosis time, year of 
transplant (defined in all statistical analyses as number of years between the day 
of transplantation and the day of data analysis, to consider time era)) was 
investigated using univariate logistic regression. For multivariate analysis, all 
variables associated with DGF in the univariate analysis with p value < 0.05 were 
entered. The association of donor last serum creatinine level, donor age, donor 
class (SCD vs. ECD), recipient age, recipient BMI, total number of HLA 
mismatch, cold ischemia time, year of transplant, DGF, and acute rejection 
during the first three months after transplantation with allograft function at 3 
months, 1, 2 and 3 years post-transplant was investigated using univariate and 
multivariate linear regression models. To assess the association of these 
variables with the repeated measures of allograft function, we used a mixed- 
models repeated-measures analysis with an autoregressive covariance matrix, 
as based on the lowest Akaike’s information criterion. Also, Kruskal-Wallis test 
was used to analyse the difference in estimated GFR according to anastomosis 
time, grouped as 35 minutes or shorter, between 36 and 45 minutes and longer 
than 45 minutes. Post hoc analysis was done by Dunn’s multiple comparisons 
test. We used Kaplan-Meier curves to show allograft survival with associated p 
values derived from the univariate log-rank test. Multivariate Cox proportional 
hazards analysis was used to investigate the effect of anastomosis time on 
survival corrected for independent variables significantly associated with survival 
in the univariate analysis. Histologic features were dichotomized as absent (if 
grade 0) or present (if grade 1 to 3) for logistic regression. Only variables 
significant in the univariate analyses were entered in the multivariate analyses. 
The effect on the repeatedly measured histologic features as a binary logistic 
response variable was measured by generalized linear models. The effect of 
anastomosis time on CADI was investigated with linear regression analysis and 
mixed-models repeated-measurements analysis with a compound symmetry 
covariance matrix, as based on the lowest Akaike’s information criterion. Two-
sided p values of less than 0.05 were considered to indicate statistical 
significance. We used SPSS software, version 22, for all statistical analyses and 
GraphPad Prism, version 6.0 (GraphPad Software), for data presentation. 
 
 
Results 
 
Patients 
A total of 679 first, single kidney transplantations from brain dead donors were 
performed during the study period. Six recipients were excluded from the 
analysis because of the presence of donor warm ischemia time during organ 
procurement. From 669 patients anastomosis time was prospectively collected. 
All reported data refer to these patients. Median follow-up after transplantation 
was 5.53 years (3.30-7.55). Demographic and clinical characteristics of donors 
and recipients are summarized in Table 1. The median anastomosis time was 34 
minutes (30-40) (Figure S1).  
 
Determinants of the anastomosis time 
Anastomosis time correlated with recipient BMI (r= 0.14, p<0.001). There was a 
significant but very weak correlation between anastomosis time, donor age (r= 
0.09, p=0.03), and cold ischemia time (r=0.09, p=0.02). No association with other 
recipient or donor characteristics could be observed (Table S1).  
From 663 of 669 recipients, data on left or right donor kidney was available. 
There was no significant difference in anastomosis time between left and right 
donor kidneys (33 min (30-39) vs. 34 min (30-40), p=0.14). The presence of one 
or more arteries or veins did not influence anastomosis time (for arteries: 34 min 
(30-40) vs. 34 min (30-38); p=0.52, for veins: 34 min (30-40) vs. 35 min (30-41); 
p=0.56; for vessels in general: 34 min (30-40) vs. 34 min (30-38); p=0.72). 
The presence and severity of aortic calcification of the recipient was not 
associated with anastomosis time (n=250, p=0.44 and p=0.84 respectively). In 
addition, anastomosis time did not correlate with hemodynamic parameters of 
vascular stiffness, or with IMT (Table S2).  
 
Effect on DGF 
17% (n = 121) of transplant recipients experienced DGF. Longer anastomosis 
time was the strongest factor associated with DGF (p < 0.001). Other factors 
associated with an increased risk of DGF were older donor age, ECD vs. SCD, 
older recipient age, higher recipient BMI, higher number of HLA mismatches, 
longer cold ischemia time and year of transplantation (Table S3). In multivariate 
logistic regression, longer anastomosis time remained the strongest independent 
factor associated with DGF (OR per minute 1.05, 95% CI 1.02-1.07, p = 0.001), 
together with ECD, recipient BMI, total number of HLA mismatches, longer cold 
ischemia time and time period of transplantation (Table 2). In kidneys from 
donors aged 65 years or older, no association between prolonged anastomosis 
time and the occurrence of DGF was observed (OR 1.03, 95% CI 0.97–1.11, p = 
0.32).  
 
Effect on acute rejection 
There was no significant association between longer anastomosis time and the 
occurrence of acute rejection in the first 3 months after transplantation (p = 0.94).  
 
Effect on allograft function 
Longer anastomosis time associated significantly with lower estimated GFR at 3 
months (p < 0.001, beta = -0.14), at 1 year (p = 0.005, beta = -0.12), at 2 years (p 
< 0.001, beta = -0.15), and at 3 years (p = 0.02, beta = -0.12). Other factors that 
associated with lower allograft function at all time points were older donor age, 
ECD vs. SCD, year of transplant and DGF (Table S4). 
When anastomosis time was categorized in 10 minutes intervals (< 35 min, 35 - 
44 minutes, ≥ 45 min), estimated GFR differed between the groups at all time 
points (Figure 1).  
In the multivariate linear regression analysis, longer anastomosis time remained 
an independent factor associated with lower allograft function, even when 
corrected for DGF and acute rejection, up to 2 years after transplantation (Table 
3). In these multivariate models, the association of anastomosis time with 
allograft function was lower due to the presence of donor age in the model, as 
there was a significant correlation between older donor age and longer 
anastomosis time (see above). This interaction was further explored by a 
sensitivity analysis, dividing patients according to donor age (< 65 years vs. ≥ 65 
years). In recipients of kidneys from donors aged 65 years or more, no 
association between anastomosis time and estimated GFR could be observed, in 
contrast to recipients of kidneys of younger donor kidneys where the magnitude 
of the effect was higher compared to the total study cohort (Table 3, Figure 2).  
There was no interaction affect between donor age and anastomosis time (both 
as continuous variable) in the linear regression analyses of eGFR at 3 months 
(p=0.88), 1 year (p=0.95), 2 years (p=0.15) and 3 years (p=0.73). Thus, the effect 
of age is not of a simple linear form.  
When recipients were grouped according to cold ischemia time (< 15 h vs. ≥ 15 
h), the association between anastomosis time and estimated GFR was more 
pronounced in recipients with longer cold ischemia time (Table S5).  
In the mixed-models repeated-measures analysis, anastomosis time was an 
independent significant determinant of the evolution of estimated GFR after 
transplantation (p = 0.009) (Table 3).   
 
Effect on allograft survival 
There was no significantly reduced overall and death-censored allograft survival 
in patients with anastomosis time of 45 minutes or longer (log rank p = 0.07 and 
p = 0.06, respectively). There was no effect on patient survival (p = 0.38) (Figure 
3). Also in a multivariate Cox regression analysis, corrected for variables 
significantly associated with survival in a univariate analysis (donor age, donor 
criteria, total number of HLA mismatch), anastomosis time was not associated 
with death-censored allograft survival (p = 0.49). 
 
Effect on graft histology 
To investigate whether the association between longer anastomosis time and 
lower allograft function was reflected by chronic histological lesions of the graft, 
we included protocol-specified biopsies at 3, 12, and 24 months from our cohort 
that were blindly rescored in this study (186 at 3 months, 189 at 1 year, and 153 
at 2 year). We focused on interstitial fibrosis and tubular atrophy (IFTA) as this 
reflects chronic allograft injury and is associated with cold ischemia time as well 
(4). In allografts with IFTA present in protocol-specified biopsies at 1 and 2 years 
after transplantation, anastomosis time during transplantation was longer (p = 
0.03 and p = 0.002, respectively) (Figure 4). Other variables associated with 
IFTA are presented in Table S6. When adjusted for these significant variables, 
anastomosis time remained independently associated with IFTA at 1 and 2 years 
after transplantation (p = 0.04, OR 1.040 (95% CI 1.002-1.08), and p = 0.009, OR 
1.06 (95% CI 1.02-1.12), respectively) (Table S7). When substracting the role of 
its components, mainly interstitial fibrosis correlated with anastomosis time. 
Generalized linear models analysis demonstrated that anastomosis time was 
significantly associated with the presence of IFTA on serial protocol biopsies 
(univariate p < 0.001, adjusted for significant covariates p < 0.001) (Table S6). 
There was no significant and consistent correlation between any other histologic 
finding and anastomosis time (Table S8). Only in the protocol-specified biopsies 
one year after transplantation did CADI associate with anastomosis time (p = 
0.26, p = 0.04, and p = 0.11 for 3 months, 1, and 2 years after transplantation 
respectively). The overall effect of anastomosis time on the CADI score in the 
unadjusted mixed-models repeated-measures analysis was also significant (p = 
0.04).  
 
 
Discussion 
 
In recipients of kidneys from brain-dead donors, the time taken to complete the 
vascular anastomoses during transplantation associates independently with an 
increased risk of DGF, with IFTA on protocol-specified biopsies and with worse 
allograft function, up to three years after transplantation.  
 As far as we are aware, the present study is the first to investigate the effect of 
anastomosis time on DGF, allograft function, histology and survival. In our patient 
cohort every minute increase in anastomosis time was accompanied with a 5% 
increased risk of DGF, independently from other risk factors. In addition, 
prolonged anastomosis time had a detrimental effect on allograft histology and 
function up to 3 years after transplantation. Even after correction for DGF, the 
association with impaired allograft function remained up to 2 years post-
transplant. We did not observe a significant reduction in death-censored allograft 
survival with prolonged anastomosis time. However, our study did not have the 
adequate power to definitely answer this important clinical question, which has to 
be addressed in future, larger cohorts. One could speculate that by affecting 
allograft function up to 3 years after transplantation longer-term function will be 
affected as well, as allograft function at 1 year is considered the best predictor of 
long term function (16). In concordance, a large study only recently revealed an 
effect of anastomosis time on patient and allograft survival. Although the effect 
on allograft survival did not remain when adjusted for other variables in this 
study, it did when only first transplantations were considered (10).  
 
In contrast to previous studies (2-4), cold ischemia time had no effect on allograft 
function or histology in our study cohort. However, in a recent publication by 
Summers et al. duration of cold ischemia time was not associated with 
decreased allograft survival for kidneys from brain dead donors (17). Moreover, 
data from the Collaborate Transplant Study show that cold ischemic time, when 
less than 18 h, has no association with graft survival (18). It could be 
hypothesized that the range of cold ischemia time in our study cohort prevented 
us to observe any long-term effect. The low incidence of DGF in this study is 
probably also related to the short average cold ischemia time (15 ± 4h) in our 
practice. 
 
To our surprise, the effect of anastomosis time on allograft function was more 
pronounced in kidneys from younger donors. This contrasts the idea that the 
impact of prolonged ischemia is particularly detrimental in older allografts. 
However, the evidence behind this concept is based on animal studies (19), or 
based on studies in non-kidney organ transplantations that differ in methodology: 
these studies focused on recipient survival instead of long-term allograft function 
and histology (20, 21) or used a younger age as cutoff to categorize donor age 
(20). Moreover, animal studies on brain hypoxic-ischemic injury suggest that the 
susceptibility of the brain may not be linear with age, and that after a certain age 
the susceptibility to ischemia decreases (22). For example, after an hypoxic insult 
higher blood lactate and lower glucose was observed in arterial blood of younger 
animals compared to older (23). Another possibility is that the impact of donor 
age overwhelms the effect of anastomosis time in kidneys from older donors. In 
line with our observation is a study of 788 first cadaver kidney transplants by 
Asderakis et al., in which the effect of prolonged cold ischemia time on reduced 
allograft survival was more pronounced in younger kidneys (24). The analysis of 
the effect of anastomosis time according to donor age needs further confirmation 
in a larger study cohort.  
In addition, we observed that anastomosis time was in particular detrimental to 
allograft function when kidneys were previously preserved cold for 15 hours or 
more.  
 
Our observations could have been confounded by other factors that prolong the 
process to complete the vascular anastomosis as well as negatively impact the 
allograft on the short or long term. BMI of the recipient could be an example, as 
anastomosis time is reported to be longer in obese patients and obesity could 
influence allograft function (10, 25). Indeed, the higher the recipient BMI, the 
longer it took to complete the vascular anastomosis. Therefore, multivariate 
analyses were adjusted for recipient BMI and still the effect of anastomosis time 
on the increased risk of DGF and diminished long-term allograft function 
remained.  
In addition, vascular calcification on the recipient’s vascular system could have 
complicated the anastomosis process. We did not find a correlation between 
arterial calcification and anastomosis time, suggesting that this did not represent 
a major bias in our findings, although it is still possible that external iliac arteries 
might differ in regard to the presence and extent of calcification compared to the 
aorta.   
 
 
We hypothesized additionally that the shorter right renal vein might increase the 
length of anastomosis time.  A recent large study compared left and right kidney 
recipients transplanted from the same deceased donor and observed a higher 
incidence of DGF and lower one-year allograft survival for right kidneys, primarily 
attributed to surgical complications (26). In our study anastomosis time did not 
differ significantly between right and left kidney recipients and the presence of 
one or more arteries or veins did not significantly prolong anastomosis time. 
 
Our results point to the importance of protecting the kidney to warm ischemia, 
even when lasting only tens of minutes. Strategies to reduce the length of warm 
ischemia might be beneficial. Possible examples are ample exposure of the 
operative field and iliac vessels to facilitate the anastomosis, avoidance of large 
vascular patches that take longer to be sewed in, or perhaps even the use of an 
automatic anastomotic stapler device (27). One could also reduce the extent of 
warm ischemia by cooling the graft (28). Whether these strategies have a 
favorable impact on transplant outcome needs further investigation.  
 
In conclusion, prolonged anastomosis time increased the risk of DGF, evoked 
interstitial fibrosis/tubular atrophy in allografts and deteriorated allograft function 
up to 3 years after transplantation in kidney transplant recipients from brain dead 
donors.  
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Table 1: Patient and transplantation characteristics (n = 669) 
 
Donor age (years) 48 ± 15 
Donor gender  (M/F in percentage) 53/47 
Donor last serum creatinine (μmol/L)  63  ± 23 
Donor criteria (SCD vs. ECD) 470 (70%) vs. 199 (30%) 
Recipient age (years) 55 ± 13 
Recipient gender (M/F in percentage) 62/38 
Recipient BMI (kg/ m
2
) 25 ± 5 
Total HLA mismatch 3 ± 1 
Cold ischemia time (h) 15 ± 4 
Anastomosis time (min) 34 (30 - 40) 
DGF  112 (17%) 
Acute rejection first 3 months 110 (16%) 
3 month serum creatinine (mg/dl) (n = 646) 1.69 ± 0.65 
3 month eGFR (mL/min/1.73m
2
) (n = 646) 47 ± 17 
1 year serum creatinine (mg/dl) (n = 598) 1.50 ± 0.51 
1 year eGFR (mL/min/1.73m
2
) (n = 598) 52 ± 18 
2 year serum creatinine (mg/dl) (n = 512) 1.51 ± 0.58 
2 year eGFR (mL/min/1.73m
2
) (n = 512) 52 ± 18 
3 year serum creatinine (mg/dl) (n = 373) 1.57 ± 0.73 
3 year eGFR (mL/min/1.73m
2
) (n = 373) 51 ± 20 
 
Data are expressed as mean ± SD; median (interquartile range); or as number 
(percentage) where appropriate.  
 
M, male; F, female; SCD, standard criteria donation; ECD, expanded criteria 
donation; h, hours; min, minutes; DGF, delayed graft function; eGFR, estimated 
glomerular filtration rate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Determinants of delayed graft function by multivariate logistic regression 
analysis.  
 
 
 
  OR 95% CI P value 
Year of transplant (y) 0.88 0.80 – 0.97 0.008 
Donor age (y) 0.99 0.97 – 1.01 0.44 
Donor criteria (SCD vs ECD) 1.70 0.87 – 3.31 0.12 
Recipient age (y) 1.02 0.99 – 1.04 0.13 
Recipient BMI (kg/m
2
) 1.06 1.01 - 1.11 0.015 
Total number of HLA mismatch 1.13 0.96 – 1.35 0.15 
Cold ischemia time (h) 1.07 1.02 - 1.13 0.006 
Anastomosis time (min) 1.05 1.02 - 1.07 0.001 
 
A p < 0.05 is considered significant (values in bold).  
SCD, standard criteria donation; ECD, expanded criteria donation; OR, odds 
ratio; 95% CI, 95% confidence interval.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Multivariate analysis of determinants of allograft function at 3 months, 1, 
2 and 3 years after transplantation, and in general over time.  
 
 
    
3 Mo after 
Transplantation* 
1 Y after 
Transplantation* 
2 Y after 
Transplantation* 
3 Y after 
Transplantation* 
Over time° 
    Beta p value Beta p value Beta p value Beta p value p value 
All patients 
Anastomosis 
time (min) 
- 0.11 0.009 - 0.09 0.03 - 0.11 0.02 - 0.09 0.11 0.009 
 
Cold ischemia 
time (h) 
- 0.005 0.91 - 0.03 0.47 - 0.05 0.31 0.07 0.22 0.73 
 
Donor age - 0.24 <0.001 - 0.25 <0.001 - 0.26 <0.001 - 0.39 <0.001 <0.001 
 
         
 
 
         
 
Donor age 
< 65 years 
(n=580) 
Anastomosis 
time (min) 
- 0.15 0.002 - 0.15 0.003 - 0.18 <0.001 - 0.14 0.03 <0.001 
Cold ischemia 
time (h) 
- 0.003 0.96 - 0.03 0.52 - 0.06 0.29 0.05 0.39 0.64 
 
 
        
 
Donor age 
≥ 65 years 
(n=89) 
Anastomosis 
time (min) 
0.06 0.62 0.18 0.20 0.27 0.12 0.23 0.35 0.25 
Cold ischemia 
time (h) 
- 0.08 0.51 - 0.17 0.17 - 0.19 0.26 - 0.07 0.77 0.36 
 
*Multivariate linear regression analysis or °multivariate mixed-models repeated-
measurements analysis adjusted for year of transplant, donor criteria, last donor 
serum creatinine, recipient age, recipient BMI, total number of HLA mismatch, 
DGF and acute rejection during first 3 months after transplantation.  
A p < 0.05 is considered significant (values in bold). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
List of figures: 
 
Figure 1: Estimated glomerular filtration rate (eGFR) at 3 months, 1 year, 2 
years, 3 years after transplantation, according to anastomosis time, 
grouped as 35 minutes or shorter, between 36 and 45 minutes and longer 
than 45 minutes. At all time points, eGFR differs significantly (Kruskal Wallis 
test, p=0.002 at 3 months, p=0.05 at 1 year, p=0.004 at 2 years and p=0.02 at 3 
years after transplantation). Post hoc analysis by Dunn’s multiple comparisons 
test is significant (depicted as *) between recipients with anastomosis time of 45 
minutes or longer compared to recipients with anastomosis time less than 35 
minutes at all time points, and compared to recipients with anastomosis time 
between 35 and 44 minutes at 3 months after transplantation. 
 
 
Figure 2: Estimated glomerular filtration rate (eGFR) at 3 months, 1 year, 2 
years, 3 years after transplantation, according to anastomosis time (AT) 
and donor age. At all time points, eGFR differed significantly between high and 
low anastomosis time in recipients from donors aged less than 65 years, 
whereas no difference was observed in recipients from older donors. Data are 
presented in Tukey boxplots. P-value is measured by the Mann Whitney U test.  
 
Figure 3: Kaplan Meier survival curves for allograft survival (Panel A), 
death-censored allograft survival (Panel B) and recipient survival (Panel C), 
stratified by anastomosis time. Data were censored at the time of data 
extraction from the clinical follow-up database (Jul 1, 2014). P values were 
calculated with the use of the log-rank test.  
 
Figure 4: Anastomosis time according to the presence of interstitial 
fibrosis and tubular atrophy on protocol biopsies at 3 months, 1 year and 2 
years after transplantation. Data are presented in Tukey boxplots. P value is 
measured by the Mann Whitney U test.  
    
 
Figure 1: Estimated glomerular filtration rate (eGFR) at 3 months, 1 year, 2 
years, 3 years after transplantation, according to anastomosis time, 
grouped as shorter than 35 minutes, between 35 and 44 minutes and 45 
minutes or longer. At all time points, eGFR differs significantly (Kruskal Wallis 
test, p=0.002 at 3 months, p=0.05 at 1 year, p=0.004 at 2 years and p=0.02 at 3 
years after transplantation). Post hoc analysis by Dunn’s multiple comparisons 
test is significant (depicted as *) between recipients with anastomosis time of 45 
minutes or longer compared to recipients with anastomosis time less than 35 
minutes at all time points, and compared to recipients with anastomosis time 
between 35 and 44 minutes at 3 months after transplantation. 
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Figure 2: Estimated glomerular filtration rate (eGFR) at 3 months and 1, 2, 3 
years after transplantation, according to anastomosis time (AT) and donor 
age. At all time points, eGFR differed significantly between high and low 
anastomosis time in recipients from donors aged less than 65 years, whereas no 
difference was observed in recipients from older donors. Data are presented in 
Tukey boxplots. P-value is measured by the Mann Whitney U test.  
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Figure 3: Kaplan Meier survival curves for allograft survival (Panel A), 
death-censored allograft survival (Panel B) and recipient survival (Panel C), 
stratified by anastomosis time. Data were censored at the time of data 
extraction from the clinical follow-up database (Jul 1, 2014). P values were 
calculated with the use of the log-rank test.  
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Figure 4: Anastomosis time according to the presence of interstitial 
fibrosis and tubular atrophy (IFTA) on protocol biopsies at 3 months, 1 year 
and 2 years after transplantation. Data are presented in Tukey boxplots. P 
value is measured by the Mann Whitney U test.  
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